Integra Lifesciences Holdings (IART) Long-Term Deferred Tax (2016 - 2025)
Integra Lifesciences Holdings (IART) has disclosed Long-Term Deferred Tax for 17 consecutive years, with $69.9 million as the latest value for Q4 2025.
- Quarterly Long-Term Deferred Tax rose 100.02% to $69.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69.9 million through Dec 2025, up 100.02% year-over-year, with the annual reading at $69.9 million for FY2025, 100.02% up from the prior year.
- Long-Term Deferred Tax hit $69.9 million in Q4 2025 for Integra Lifesciences Holdings, down from $109.7 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $109.7 million in Q3 2025 to a low of $34.2 million in Q1 2024.
- Historically, Long-Term Deferred Tax has averaged $59.5 million across 5 years, with a median of $53.2 million in 2022.
- Biggest five-year swings in Long-Term Deferred Tax: soared 3102.83% in 2021 and later crashed 43.61% in 2022.
- Year by year, Long-Term Deferred Tax stood at $57.0 million in 2021, then fell by 19.24% to $46.0 million in 2022, then rose by 0.19% to $46.1 million in 2023, then dropped by 24.21% to $34.9 million in 2024, then surged by 100.02% to $69.9 million in 2025.
- Business Quant data shows Long-Term Deferred Tax for IART at $69.9 million in Q4 2025, $109.7 million in Q3 2025, and $102.9 million in Q2 2025.